Corbus Pharmaceuticals Holdings (CRBP) EBIT Margin Growth (1y) (2016 - 2021)
Corbus Pharmaceuticals Holdings (CRBP) EBIT Margin Growth (1y) (2016 - 2021) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 3,609.00 |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 1,536.00 |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Corbus Pharmaceuticals Holdings | 133.67 Mn | 105.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | -1.15 Mn |
| Jun 30, 2021 | 108,908.00 |
| Mar 31, 2021 | -68,334.00 |
| Dec 31, 2020 | -130,450.00 |
| Sep 30, 2020 | -179,165.00 |
| Jun 30, 2020 | -1.33 Mn |
| Mar 31, 2020 | -28,951.00 |
| Dec 31, 2019 | 884,691.00 |
| Sep 30, 2019 | 39,662.00 |
| Jun 30, 2019 | 145,772.00 |
| Mar 31, 2019 | -15,817.00 |
| Sep 30, 2018 | -49,206.00 |
| Jun 30, 2018 | 63,033.00 |
| Mar 31, 2018 | -67,230.00 |
| Sep 30, 2017 | -15,533.00 |
| Jun 30, 2017 | -102,530.00 |
| Mar 31, 2017 | 15,193.00 |
| Sep 30, 2016 | 60,460.00 |
| Jun 30, 2016 | 119,828.00 |